knowledge -WSS

knowledge

author：knowledge 2025-09-03 05:36:33 - browse：19

Sanofi CEO Paul Hudson Courtesy Sanofi

NEW YORK — The top executives at French drug giant Sanofi on Wednesday defended their decision to reduce earnings forecasts for 2024 in order to fund more research studies of new medicines they say could one day generate billions of dollars in annual sales.

CEO Paul Hudson and Houman Ashrafian, Sanofi’s new head of R&D, made their remarks in an exclusive interview with STAT ahead of a full-day meeting with analysts here. When the cuts to earnings were first announced Oct. 27, along with a plan to spin off the company’s consumer products division, shares dove 18% and have yet to fully recover. The share price is down 5% since the beginning of 2023.

“I’ve been waiting four years for a situation where we could put [out] the pipeline, as impressive as it is, and declare that we’re going to be the world’s leading immunology company,” said Hudson, who took over as CEO in 2019. “So it’s quite an important moment for us. And it’s an important moment to declare that we’re back in science, because I could argue that we haven’t been where we needed to be.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Trump seeks lengthy delay of classified docs trial, citing upcoming election

explore

WSS

A look at other Americans who have crossed into North Korea over the years

Twill hunts for pharma partner to market its depression app

BridgeBio heart drug succeeds in pivotal study

Ford plant in Missouri shuts down over 'possible threat,' sheriff's office says

Titanic submersible: What a 'catastrophic implosion' means and what officials found

Biden administration sends mixed signals on US soldier who crossed into North Korea

entertainment

knowledge

hotspot

Hollywood unions extend contract negotiations for actors

Asa Hutchinson previews new plan to reform federal law enforcement if elected in 2024

Anesthesiologist group: stop taking Ozempic before surgery

Ford plant in Missouri shuts down over 'possible threat,' sheriff's office says

In age of alternative facts, a scholarly course on calling out crap

Vivek Ramaswamy, who's embraced Trump on the campaign trail, condemned him after Jan. 6

How to save PrEP access — and even expand it

Father who lunged at Larry Nassar comforted by deputy who pinned him down: 'I understand'

How to save PrEP access — and even expand it

Ford plant in Missouri shuts down over 'possible threat,' sheriff's office says

Wikipedia

UPS workers' union leader explains what's at stake as strike edges closer

House passes resolution saying Israel isn't a 'racist or apartheid state'

FDA approves Leqembi, a milestone in Alzheimer’s treatment

Titanic submersible: What a 'catastrophic implosion' means and what officials found

Titanic submersible victims' family mourns: 'Enormous tragedy and devastation'

15 die by electrocution after transformer explodes in northern India

explore

explore

explore

Wikipedia